Dudediligence.

Pulse Biosciences, Inc

PLSENASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$2,818,750

2 notices · 125,000 sh

Oct 2025 to Oct 2026

Reported ·

$2,932,200

7 sales · 6 buys · $13.5M bought

Oct 2025 to Sep 2026

The two figures cover different periods.

All 7 reported sales carry the 10b5-1 box. Together they are 0.18% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Sep 2026N2025DJ2026FMAMJJASO2026-02-12: KEVIN DANAHY, Form 1442026-02-09: KEVIN DANAHY, Form 1442026-02-09: Danahy Kevin Patrick, sold2026-02-12: Danahy Kevin Patrick, sold2026-02-18: Danahy Kevin Patrick, sold2026-05-11: DUGGAN ROBERT W, bought2026-05-11: LAVIOLETTE PAUL A, bought2026-08-26: Teplitsky Liane Rae, bought2026-08-31: Teplitsky Liane Rae, bought
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-02-12KEVIN DANAHY, Chief Commercial Officer$1,262,500
50,000 shplan 2025-05-14144 ↗
Form 4, 2026-02-17: sold 60,000 at $23.51 Form 4 ↗
2026-02-09KEVIN DANAHY, Chief Commercial Officer$1,556,250
75,000 shplan 2025-05-14144 ↗
Form 4, 2026-02-11: sold 60,000 at $23.39 Form 4 ↗